Controlled Substances

Opioids

For more information, see pain control

Benzodiazepines

General information

Risks

  • May worsen PTSD symptoms

  • Risks while driving: Same as BAC between 0.050% and 0.079%

  • Increase risk for hip fractures by 1.5 to 2.55 times

  • Long term use: Substantial cognitive decline that did not resolve 3 months after discontinuation

  • Beers criteria

    • May be appropriate for seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, periprocedural anesthesia, end-of-life care

    • Avoid benzodiazepines (any type) for treatment of insomnia, agitation, or delirium due to increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents (SOR Strong)

    • Benzodiazepine-receptor agonists

      • Adverse events are similar to those of benzodiazepines in older adults

      • Avoid chronic use, i.e. > 90 days (SOR Strong)

Agents with Primary Care Prescribing Suggestions

Use

Start taper for any patient taking daily benzodiazepines for > 1 month, especially:

  • Age > 65 years

  • If also taking opioids or amphetamines

  • In patients with history of a substance abuse, cognitive disorder, and/or TBI

Codes

  • Code A - Panic Disorder

  • Code B - Behavior/Attention Deficit

  • Code C - Chronic Debilitation/Neurological Disorder/Seizures etc

  • Code D - Chronic pain/Incurable

  • Code E - Narcolepsy

  • Code F - Hormone Deficiency/Metastatic Breast Cancer